Moderna reports positive early results from coronavirus vaccine trial

0
1

In a major development, biotech firm Moderna on Monday announced that early-stage human trial for its coronavirus vaccine produced COVID-19 antibodies in all 45 participants. Releasing the data on the human trial of the vaccine, Moderna chief medical officer Dr. Tal Zaks said that each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group.

NO COMMENTS